Core Viewpoint - The company has developed an efficient technical service system over years of exploration and growth, focusing on customer-centric principles and establishing a leading vaccine market service team to provide professional business support, marketing services, and information services [1] Group 1 - The company emphasizes a customer-centric approach in its operations [1] - A leading team in the vaccine market service has been established to ensure effective communication and timely handling of customer inquiries and demands [1] - High-level technical service personnel and an improving management system support the promotional services [1] Group 2 - The company commits to fulfilling information disclosure obligations in accordance with relevant laws and regulations if there are related plans [1]

Group 1 - The board of directors of CITIC Guoan Information Industry Co., Ltd. held its 21st meeting on January 23, 2026, with all 7 directors present, and the meeting was chaired by Chairman Wang Meng [1][3][11] - The board approved several proposals, including the establishment of a "Director's Compensation Management Method," a "Director's Departure Management Method," and a "Board Diversity Policy," all aimed at enhancing corporate governance and decision-making [3][5][7] - The board also approved the estimated daily related transactions for 2026 and the re-evaluation of the borrowing limit from related parties, which includes a request to increase the borrowing limit by up to 5 billion yuan [8][9][33] Group 2 - The company plans to hold its first temporary shareholders' meeting of 2026 on February 9, 2026, to review the proposals approved by the board, with a record date of February 2, 2026 [11][52][56] - The estimated daily related transactions for 2026 involve providing services to CITIC Bank and CITIC Securities, as well as purchasing commercial insurance from CITIC Prudential Life Insurance [16][18] - The company has applied for a borrowing limit of up to 10 billion yuan from CITIC Group and its subsidiaries, with a borrowing term of no more than 5 years, and plans to increase this limit by an additional 5 billion yuan [32][49][50]

Group 1 - The core business of the company is to provide market business and service support for vaccine manufacturers, which includes business support services, marketing services, and information services [2] - Currently, the company has not invested in research related to AI healthcare or AI pharmaceuticals [2]

Core Viewpoint - The company, Jian Design (300668.SZ), primarily provides market business and service support for vaccine manufacturers, including business support services, marketing services, and information services. The company has not collaborated with Moore Threads [1]. Group 1 - The main business of the company is to offer market business and service support to vaccine manufacturers [1]. - The services provided by the company include business support services, marketing services, and information services [1]. - The company has confirmed that it has not engaged in any collaboration with Moore Threads [1].